Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial

Casper Steenholdt; Jorn Brynskov; Ole. Thomsen; Lars K. Munck; Jan Fallingborg; Lisbet A. Christensen; Gitte Pedersen; Jens Kjeldsen; Bent A. Jacobsen; Anne Sophie Oxholm; Jakob Kjellberg; Klaus Bendtzen; Mark A. Ainsworth

doi:10.1016/S0016-5085(13)60074-8

Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial

Casper Steenholdt, Jorn Brynskov, Ole. Thomsen, Lars K. Munck, Jan Fallingborg, Lisbet A. Christensen, Gitte Pedersen, Jens Kjeldsen, Bent A. Jacobsen, Anne Sophie Oxholm, Jakob Kjellberg, Klaus Bendtzen, Mark A. Ainsworth

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	94
Journal	Gastroenterology
Volume	144
Issue number	5, Supplement 1
Pages (from-to)	22
ISSN	0016-5085
DOIs	https://doi.org/10.1016/S0016-5085(13)60074-8
Publication status	Published - 2013

Documents & Links

10.1016/S0016-5085(13)60074-8

Cite this

Steenholdt, C., Brynskov, J., Thomsen, O., Munck, L. K., Fallingborg, J., Christensen, L. A., Pedersen, G., Kjeldsen, J., Jacobsen, B. A., Oxholm, A. S., Kjellberg, J., Bendtzen, K., & Ainsworth, M. A. (2013). Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial. Gastroenterology, 144(5, Supplement 1), 22 . [94]. https://doi.org/10.1016/S0016-5085(13)60074-8

Steenholdt, Casper ; Brynskov, Jorn ; Thomsen, Ole. et al. / Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab : The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial. In: Gastroenterology. 2013 ; Vol. 144, No. 5, Supplement 1. pp. 22 .

@article{f38a8c8297ae4162a367450e69299c37,

title = "Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial",

author = "Casper Steenholdt and Jorn Brynskov and Ole. Thomsen and Munck, {Lars K.} and Jan Fallingborg and Christensen, {Lisbet A.} and Gitte Pedersen and Jens Kjeldsen and Jacobsen, {Bent A.} and Oxholm, {Anne Sophie} and Jakob Kjellberg and Klaus Bendtzen and Ainsworth, {Mark A.}",

year = "2013",

doi = "10.1016/S0016-5085(13)60074-8",

language = "English",

volume = "144",

pages = "22 ",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "Elsevier",

number = "5, Supplement 1",

}

Steenholdt, C, Brynskov, J, Thomsen, O, Munck, LK, Fallingborg, J, Christensen, LA, Pedersen, G, Kjeldsen, J, Jacobsen, BA, Oxholm, AS, Kjellberg, J, Bendtzen, K & Ainsworth, MA 2013, 'Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial', Gastroenterology, vol. 144, no. 5, Supplement 1, 94, pp. 22 . https://doi.org/10.1016/S0016-5085(13)60074-8

Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab : The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial. / Steenholdt, Casper; Brynskov, Jorn; Thomsen, Ole. et al.

In: Gastroenterology, Vol. 144, No. 5, Supplement 1, 94, 2013, p. 22 .

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab

T2 - The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial

AU - Steenholdt, Casper

AU - Brynskov, Jorn

AU - Thomsen, Ole.

AU - Munck, Lars K.

AU - Fallingborg, Jan

AU - Christensen, Lisbet A.

AU - Pedersen, Gitte

AU - Kjeldsen, Jens

AU - Jacobsen, Bent A.

AU - Oxholm, Anne Sophie

AU - Kjellberg, Jakob

AU - Bendtzen, Klaus

AU - Ainsworth, Mark A.

PY - 2013

Y1 - 2013

U2 - 10.1016/S0016-5085(13)60074-8

DO - 10.1016/S0016-5085(13)60074-8

M3 - Conference abstract in journal

SN - 0016-5085

VL - 144

SP - 22

JO - Gastroenterology

JF - Gastroenterology

IS - 5, Supplement 1

M1 - 94

ER -

Steenholdt C, Brynskov J, Thomsen O, Munck LK, Fallingborg J, Christensen LA et al. Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial. Gastroenterology. 2013;144(5, Supplement 1):22 . 94. doi: 10.1016/S0016-5085(13)60074-8